MELBOURNE, Australia (Dec. 13)—Pacific Dunlop Ltd. will initiate a strategic review of Ansell Healthcare Products Inc. to establish the future course of the global health care operation. The company waited until it had completed the sale of its Pacific Brands division to a consortium for $730 million before launching the probe. The sale was finalized Nov. 30. E.D. Tweddell, who recently replaced John Ralph as chairman of the firm, will lead the review process of Ansell, working with Harry Boon, the managing director for Red Bank, N.J.-based Ansell. "The review will determine the best possible shape of the Ansell business for the future," the new chairman said. With the sale of its Pacific Brands division, Pacific Dunlop's remaining subsidiaries are Ansell and South Pacific Tyres Ltd., an Australian joint venture it has with Goodyear.